Obese non-Hodgkin lymphoma patients tolerate full uncapped doses of chemotherapy with no increase in toxicity, and a similar survival to that seen in nonobese patients.
Saved in:
| Title: | Obese non-Hodgkin lymphoma patients tolerate full uncapped doses of chemotherapy with no increase in toxicity, and a similar survival to that seen in nonobese patients. |
|---|---|
| Authors: | Chan, Henry1 (AUTHOR), Jackson, Sharon1 (AUTHOR), McLay, Jessica2 (AUTHOR), Knox, Angela1 (AUTHOR), Lee, Jae1 (AUTHOR), Wang, Sarah1 (AUTHOR), Issa, Samar1 (AUTHOR) Samar.issa@middlemore.co.nz |
| Source: | Leukemia & Lymphoma. Nov2016, Vol. 57 Issue 11, p2584-2592. 9p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 10428194 |
|---|---|
| DOI: | 10.3109/10428194.2016.1151508 |
